Abstract:Recent studies have shown that blood flow through the internal mammary artery graft is inadequate for maximal exercise and that hypoperfusion may be worsened by high-dose vasopressor therapy that could further reduce arterial graft flow. Histologic studies have suggested that the human internal mammary artery is an elastic “passive conduit” along the majority of its length. However, although the pharmacologic reactivity at the distal section of the internal mammary artery has been extensively studied, this evaluation has never been done at the middle and proximal sections. It is extremely important to understand the contractility at the midsection of the internal mammary artery because, in a critical situation, any contraction may further reduce the internal mammary artery flow. The present study was designed to investigate the following: (1) Is it true that the pharmacologic reactivity of the human internal mammary artery is different among various sections? and (2) Is the human internal mammary artery a nonreactive “passive conduit” at its most important area used as the graft—the middle and the proximal sections? One hundred six human internal mammary artery ring segments taken from patients who underwent internal mammary artery grafting procedures (29 from the proximal, 38 from the middle, and 39 from the distal sections) were studied in the organ bath under a physiologic pressure. Concentration-response curves were established for norepinephrine, endothelin-1, U46619, potassium, and glyceryl trinitrate (precontracted with 10 nmol/L U46619). Contraction forces were standardized (in grams per millimeter circumference) at a pressure of 100 mm Hg. The contraction force was greater in the distal section than in other sections for norepinephrine ( p = 0.002) and endothelin-1 ( p = 0.04). No differences were seen for potassium, U46619, or glyceryl trinitrate, whereas the effective concentration inducing 50% of maximal response for U46619 was 100-fold lower in the distal than in the middle section (9.06 ± 0.34 versus 7.06 ± 0.48 -log M; p = 0.01) indicating higher sensitivity in the distal section. This study for the first time shows various reactivity along the full length of the human internal mammary artery and shows that the distal section is the most reactive part of the graft. However, although the middle and the proximal sections are less reactive to some vasoconstrictors (norepinephrine and endothelin-1), it is not a “passive conduit” and it contracts with all four vasoconstrictors tested. The contractility at the midsection should be fully appreciated because, under critical postoperative situations (hypoperfusion) or during exercise with marginal flow, the ability of these sections to contract in response to vasoconstrictors may become clinically detrimental and require pharmacologic therapy. (J THORAC CARDIOVASC SURG 1994;108:741-6)

Inhibitory Effects of Glyceryl Trinitrate on Alpha-Adrenoceptor Mediated Contraction in the Human Internal Mammary Artery.

Inhibitory effects of calcium antagonists on alpha-adrenoceptor-mediated contraction in the human internal mammary artery.

Predominant Α1adrenoceptor-Mediated Contraction in the Human Internal Mammary Artery

Interaction Between Endothelin and Vasodilators in the Human Internal Mammary Artery.

Reactivity of Human Isolated Internal Mammary Artery to Constrictor and Dilator Agents - Implications for Treatment of Internal Mammary Artery Spasm

Comparison of Nitroprusside and Nitroglycerin in Inhibition of Angiotensin Ii and Other Vasoconstrictor-Mediated Contraction in Human Coronary Bypass Conduits

Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries.

Interaction Between Vasodilators and Vasopressin in Internal Mammary Artery and Clinical Significance.

Vascular Endothelial Growth Factor-Mediated, Endothelium-Dependent Relaxation In Human Internal Mammary Artery

Pharmacologic Dilatation of the Internal Mammary Artery During Coronary Bypass Grafting.

Contractile effect of trimethylamine and trimethylamine-n-oxide on isolated human umbilical arteries

Endothelium-dependent Vasorelaxant Effect of Procyanidin B2 on Human Internal Mammary Artery.

PP098—Nicorandil induced endothelium-independent relaxation of arterial bypass graft

Reactivity of the canine isolated internal mammary artery, saphenous vein, and coronary artery to constrictor and dilator substances: relevance to coronary bypass graft surgery.

Effect of Thromboxane A2 Antagonist GR32191B on Prostanoid and Nonprostanoid Receptors in the Human Internal Mammary Artery

Middle and proximal sections of the human internal mammary artery are not “passive conduits”

The Interaction Between Human Urotensin II and Vasodilator Agents in Human Internal Mammary Artery with Possible Clinical Implications

Effects of Potassium Channel Opener KRN4884 on Human Conduit Arteries Used As Coronary Bypass Grafts.

Inhibition of Vasoconstriction by Aj-2615, A Novel Calcium Antagonist with Alpha(1)-Adrenergic Receptor Blocking Activity in Human Conduit Arteries Used As Bypass Grafts

Interaction of Human Urotensin Ii and Vasodilator Agents in Human Internal Mammary Artery